Asia Pacific PCR Technologies Market Forecast to 2030 - Regional Analysis - by Technology (Real-Time PCR, Conventional PCR, Reverse Transcription PCR, Digital PCR, Multiplex RT PCR, Hot Start PCR, and Others), Offerings (Reagents & Consumables, Instruments, and Software & Services), Application (Gene Expression Analysis, Genetic Sequencing, Genotyping, Nucleic Acid Synthesis, Standard Validation, Point of Care Diagnostics, Environmental Application, and Others), and End User (Hospitals & Diagnostic Centers, Academia & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others)
The Asia Pacific PCR technologies market is expected to grow from US$ 2,835.20 million in 2022 to US$ 5,465.60 million by 2030. It is estimated to record a CAGR of 8.6% from 2022 to 2030.
Surging Investments and Funds Availability for PCR Technologies Boost Asia Pacific PCR Technologies Market
Government and federal agencies worldwide recognize the role of quantitative polymerase chain reaction (qPCR) and dPCR products in genome-based research in 2023, Mirxes, a leading innovator in RNA technology, specializes in accurate, non-invasive, and reasonably priced blood-based miRNA testing kits for early disease detection, particularly cancer, raised US $50 million in a Series D funding round. The company's main offering, GASTROClear, is an in vitro diagnostic test that uses PCR to detect stomach cancer early on. It has been designated as a Breakthrough Device by the US FDA. This is the first time that the US FDA has given such a classification to an IVD test for early diagnosis of stomach cancer, a molecular IVD test from Southeast Asia, and a blood miRNA test worldwide. Some companies have also increased their research and development funds for the enhancement of gene synthesis. In In 2022, Temasek contributed US $85 million to the healthtech business Molbio Diagnostics, located in India. Molbio designs portable diagnostic tools for a range of conditions, including HIV, dengue, malaria, hepatitis, and tuberculosis (TB). In 2021, in a Series E+ fundraising round, Ustar, a Chinese point-of-care (POC) business that creates molecular diagnostic tools, raised roughly US$ 2.6 million. Ustar will use a portion of the funds raised to improve the effectiveness of their flagship high-throughput, completely automated nucleic acid amplification test instrument. The remaining funds will go into developing a next generation testing platform, increasing the variety of tests offered, and mass-producing polymerase chain reaction (PCR) testing kits for home usage.
Therefore, the increasing availability of financial support for research and development in disease-specific genomics propels the demand for PCR technologies.
Asia Pacific PCR Technologies Market Overview
The Asia Pacific PCR technologies market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The market growth in Asia Pacific is mainly attributed to the increasing foreign direct investments; the large availability of highly skilled, efficient workforces; and streamlining government policies resulting in high investments in the biotechnology sector. In addition, increasing cases of infectious and chronic diseases, and government and non-government initiatives fuel the growth of the PCR technologies market in Asia Pacific. The projected growth of the PCR technologies market in China during the forecast period is attributed to the increasing demand for high-quality healthcare products, growing prevalence of lifestyle diseases in the country, rising developments in diagnostics technologies, surging number of diagnostic centers and hospitals, and the ongoing modernization of medical facilities in hospitals. In China, PCR techniques are used for preimplantation genetic diagnosis (PGD), cancer treatment, and noninvasive prenatal testing (NIPT). According to the article "Rare Disease Day: why China's Rare Disease Burden Could Be an Opportunity for Innovation," published in February 2023, ~20 million Chinese people suffer from rare diseases. PCR techniques such as dPCR and qPCR can be used in the diagnosis and treatment (to monitor treatment response) of such rare conditions. The rising prevalence of cancer in China also contributes to the PCR technologies market growth. According to the Global Cancer Observatory data, ~4.6 million cancer cases were reported in the country in 2020. In addition, cancer resulted in the death of 3.1 million people in China. China PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn) In terms of value, the PCR technologies market in China was valued at US$ 776.23 million in 2022 and is projected to reach US$ 1,545.21 million by 2030; it is expected to register a CAGR of 9.00% during the forecast period.
Asia Pacific PCR Technologies Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific PCR Technologies Market Segmentation
The Asia Pacific PCR technologies market is segmented into technology, offerings, application, end user, and country.
Based on technology, the Asia Pacific PCR technologies market is segmented into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held largest share of Asia Pacific PCR technologies market in 2022.
In terms of offerings, the Asia Pacific PCR technologies market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of Asia Pacific PCR technologies market in 2022. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR, and portable thermocyclers/PCR.
By application, the Asia Pacific PCR technologies market is segmented gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held the largest share of Asia Pacific PCR technologies market in 2022.
Based on end user, the Asia Pacific PCR technologies market is segmented hospitals & diagnostic centers, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centers segment held the largest share of Asia Pacific PCR technologies market in 2022.
By country, the Asia Pacific PCR technologies market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific PCR technologies market in 2022.
Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Takara Bio Inc, Standard Bio Tools Inc, Agilent Technologies Inc, and Ellume Ltd are some of the leading companies operating in the Asia Pacific PCR technologies market.
Surging Investments and Funds Availability for PCR Technologies Boost Asia Pacific PCR Technologies Market
Government and federal agencies worldwide recognize the role of quantitative polymerase chain reaction (qPCR) and dPCR products in genome-based research in 2023, Mirxes, a leading innovator in RNA technology, specializes in accurate, non-invasive, and reasonably priced blood-based miRNA testing kits for early disease detection, particularly cancer, raised US $50 million in a Series D funding round. The company's main offering, GASTROClear, is an in vitro diagnostic test that uses PCR to detect stomach cancer early on. It has been designated as a Breakthrough Device by the US FDA. This is the first time that the US FDA has given such a classification to an IVD test for early diagnosis of stomach cancer, a molecular IVD test from Southeast Asia, and a blood miRNA test worldwide. Some companies have also increased their research and development funds for the enhancement of gene synthesis. In In 2022, Temasek contributed US $85 million to the healthtech business Molbio Diagnostics, located in India. Molbio designs portable diagnostic tools for a range of conditions, including HIV, dengue, malaria, hepatitis, and tuberculosis (TB). In 2021, in a Series E+ fundraising round, Ustar, a Chinese point-of-care (POC) business that creates molecular diagnostic tools, raised roughly US$ 2.6 million. Ustar will use a portion of the funds raised to improve the effectiveness of their flagship high-throughput, completely automated nucleic acid amplification test instrument. The remaining funds will go into developing a next generation testing platform, increasing the variety of tests offered, and mass-producing polymerase chain reaction (PCR) testing kits for home usage.
Therefore, the increasing availability of financial support for research and development in disease-specific genomics propels the demand for PCR technologies.
Asia Pacific PCR Technologies Market Overview
The Asia Pacific PCR technologies market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The market growth in Asia Pacific is mainly attributed to the increasing foreign direct investments; the large availability of highly skilled, efficient workforces; and streamlining government policies resulting in high investments in the biotechnology sector. In addition, increasing cases of infectious and chronic diseases, and government and non-government initiatives fuel the growth of the PCR technologies market in Asia Pacific. The projected growth of the PCR technologies market in China during the forecast period is attributed to the increasing demand for high-quality healthcare products, growing prevalence of lifestyle diseases in the country, rising developments in diagnostics technologies, surging number of diagnostic centers and hospitals, and the ongoing modernization of medical facilities in hospitals. In China, PCR techniques are used for preimplantation genetic diagnosis (PGD), cancer treatment, and noninvasive prenatal testing (NIPT). According to the article "Rare Disease Day: why China's Rare Disease Burden Could Be an Opportunity for Innovation," published in February 2023, ~20 million Chinese people suffer from rare diseases. PCR techniques such as dPCR and qPCR can be used in the diagnosis and treatment (to monitor treatment response) of such rare conditions. The rising prevalence of cancer in China also contributes to the PCR technologies market growth. According to the Global Cancer Observatory data, ~4.6 million cancer cases were reported in the country in 2020. In addition, cancer resulted in the death of 3.1 million people in China. China PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn) In terms of value, the PCR technologies market in China was valued at US$ 776.23 million in 2022 and is projected to reach US$ 1,545.21 million by 2030; it is expected to register a CAGR of 9.00% during the forecast period.
Asia Pacific PCR Technologies Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific PCR Technologies Market Segmentation
The Asia Pacific PCR technologies market is segmented into technology, offerings, application, end user, and country.
Based on technology, the Asia Pacific PCR technologies market is segmented into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held largest share of Asia Pacific PCR technologies market in 2022.
In terms of offerings, the Asia Pacific PCR technologies market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of Asia Pacific PCR technologies market in 2022. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR, and portable thermocyclers/PCR.
By application, the Asia Pacific PCR technologies market is segmented gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held the largest share of Asia Pacific PCR technologies market in 2022.
Based on end user, the Asia Pacific PCR technologies market is segmented hospitals & diagnostic centers, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centers segment held the largest share of Asia Pacific PCR technologies market in 2022.
By country, the Asia Pacific PCR technologies market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific PCR technologies market in 2022.
Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Takara Bio Inc, Standard Bio Tools Inc, Agilent Technologies Inc, and Ellume Ltd are some of the leading companies operating in the Asia Pacific PCR technologies market.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. ASIA PACIFIC PCR TECHNOLOGIES MARKET - KEY INDUSTRY DYNAMICS
4.1 PCR Technologies Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Rising Prevalence of Genetic and Infectious Diseases
4.2.2 Surging Investments and Funds Availability for PCR Technologies
4.3 Market Restraints
4.3.1 High Costs of PCR Systems and Availability of Alternative Assays
4.4 Market Opportunities
4.4.1 Increasing Adoption of PCR Techniques in Emerging Countries
4.4.2 Increasing Demand for POC Testing
4.5 Future Trends
4.5.1 Advancements in PCR Technologies
4.6 Impact of Drivers and Restraints:
5. PCR TECHNOLOGIES MARKET - ASIA PACIFIC MARKET ANALYSIS
5.1 PCR Technologies Market Revenue (US$ Million), 2020 - 2030
6. ASIA PACIFIC PCR TECHNOLOGIES MARKET ANALYSIS - BY TECHNOLOGY
6.1 Overview
6.2 Real Time PCR
6.2.1 Overview
6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Conventional PCR
6.3.1 Overview
6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Reverse Transcription PCR
6.4.1 Overview
6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.5 Digital PCR
6.5.1 Overview
6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.6 Multiplex RT PCR
6.6.1 Overview
6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.7 Hot Start PCR
6.7.1 Overview
6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.8 Others
6.8.1 Overview
6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
7. ASIA PACIFIC PCR TECHNOLOGIES MARKET ANALYSIS - BY OFFERINGS
7.1 Overview
7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
7.3 Reagents and Consumables
7.3.1 Overview
7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
7.3.2.1.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
7.5 Software and Services
7.5.1 Overview
7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)
8. ASIA PACIFIC PCR TECHNOLOGIES MARKET ANALYSIS - BY APPLICATION
8.1 Overview
8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Gene Expression Analysis
8.3.1 Overview
8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Genetic Sequencing
8.4.1 Overview
8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
8.5 Genotyping
8.5.1 Overview
8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
8.6 Nucleic Acid Synthesis
8.6.1 Overview
8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
8.7 Standard Validation
8.7.1 Overview
8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
8.8 Point of Care Diagnostics
8.8.1 Overview
8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
8.9 Environmental Application
8.9.1 Overview
8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
8.10 Others
8.10.1 Overview
8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
9. ASIA PACIFIC PCR TECHNOLOGIES MARKET ANALYSIS - BY END USER
9.1 Overview
9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals and Diagnostic Centers
9.3.1 Overview
9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
9.4 Academia and Research Institutes
9.4.1 Overview
9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
9.5 Pharmaceutical and Biotechnology Companies
9.5.1 Overview
9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
10. ASIA PACIFIC PCR TECHNOLOGIES MARKET -COUNTRY ANALYSIS
10.1 Asia Pacific: PCR Technologies Market
10.1.1 Overview
10.1.2 Asia Pacific PCR Technologies Market Revenue and Forecast and Analysis - By Country
10.1.2.1 China
10.1.2.1.1 Overview
10.1.2.2 China PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.2.1 China PCR Technologies Market Breakdown by Technology
10.1.2.2.2 China PCR Technologies Market Breakdown by Offerings
10.1.2.2.2.1 China PCR Technologies Market Breakdown by Instruments
10.1.2.2.2.2 China PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.2.2.2.1 China PCR Technologies Market Breakdown by Vial Size
10.1.2.2.3 China PCR Technologies Market Breakdown by Application
10.1.2.2.4 China PCR Technologies Market Breakdown by End User
10.1.2.3 Japan
10.1.2.3.1 Overview
10.1.2.4 Japan PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.4.1 Japan PCR Technologies Market Breakdown by Technology
10.1.2.4.2 Japan PCR Technologies Market Breakdown by Offerings
10.1.2.4.2.1 Japan PCR Technologies Market Breakdown by Instruments
10.1.2.4.2.2 Japan PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.4.2.2.1 Japan PCR Technologies Market Breakdown by Vial Size
10.1.2.4.3 Japan PCR Technologies Market Breakdown by Application
10.1.2.4.4 Japan PCR Technologies Market Breakdown by End User
10.1.2.5 India
10.1.2.5.1 Overview
10.1.2.6 India PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.6.1 India PCR Technologies Market Breakdown by Technology
10.1.2.6.2 India PCR Technologies Market Breakdown by Offerings
10.1.2.6.2.1 India PCR Technologies Market Breakdown by Instruments
10.1.2.6.2.2 India PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.6.2.2.1 India PCR Technologies Market Breakdown by Vial Size
10.1.2.6.3 India PCR Technologies Market Breakdown by Application
10.1.2.6.4 India PCR Technologies Market Breakdown by End User
10.1.2.7 Australia
10.1.2.7.1 Overview
10.1.2.8 Australia PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.8.1 Australia PCR Technologies Market Breakdown by Technology
10.1.2.8.2 Australia PCR Technologies Market Breakdown by Offerings
10.1.2.8.2.1 Australia PCR Technologies Market Breakdown by Instruments
10.1.2.8.2.2 Australia PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.8.2.2.1 Australia PCR Technologies Market Breakdown by Vial Size
10.1.2.8.3 Australia PCR Technologies Market Breakdown by Application
10.1.2.8.4 Australia PCR Technologies Market Breakdown by End User
10.1.2.9 South Korea
10.1.2.9.1 Overview
10.1.2.10 South Korea PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.10.1 South Korea PCR Technologies Market Breakdown by Technology
10.1.2.10.2 South Korea PCR Technologies Market Breakdown by Offerings
10.1.2.10.2.1 South Korea PCR Technologies Market Breakdown by Instruments
10.1.2.10.2.2 South Korea PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.10.2.2.1 South Korea PCR Technologies Market Breakdown by Vial Size
10.1.2.10.3 South Korea PCR Technologies Market Breakdown by Application
10.1.2.10.4 South Korea PCR Technologies Market Breakdown by End User
10.1.2.11 Rest of Asia Pacific
10.1.2.11.1 Overview
10.1.2.12 Rest of Asia Pacific PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.12.1 Rest of Asia Pacific PCR Technologies Market Breakdown by Technology
10.1.2.12.2 Rest of Asia Pacific PCR Technologies Market Breakdown by Offerings
10.1.2.12.2.1 Rest of Asia Pacific PCR Technologies Market Breakdown by Instruments
10.1.2.12.2.2 Rest of Asia Pacific PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.12.2.2.1 Rest of Asia Pacific PCR Technologies Market Breakdown by Vial Size
10.1.2.12.3 Rest of Asia Pacific PCR Technologies Market Breakdown by Application
10.1.2.12.4 Rest of Asia Pacific PCR Technologies Market Breakdown by End User
11. PCR TECHNOLOGIES MARKET-INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the PCR Technologies Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Thermo Fisher Scientific Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Promega Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN NV
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 bioMerieux SA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Hoffmann-La Roche Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Bio-Rad Laboratories Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Becton Dickinson and Co
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Takara Bio Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Standard Biotools Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Agilent Technologies Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Ellume Ltd
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. APPENDIX
13.1 About the Insight Partners
13.2 Glossary of Terms
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. ASIA PACIFIC PCR TECHNOLOGIES MARKET - KEY INDUSTRY DYNAMICS
4.1 PCR Technologies Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Rising Prevalence of Genetic and Infectious Diseases
4.2.2 Surging Investments and Funds Availability for PCR Technologies
4.3 Market Restraints
4.3.1 High Costs of PCR Systems and Availability of Alternative Assays
4.4 Market Opportunities
4.4.1 Increasing Adoption of PCR Techniques in Emerging Countries
4.4.2 Increasing Demand for POC Testing
4.5 Future Trends
4.5.1 Advancements in PCR Technologies
4.6 Impact of Drivers and Restraints:
5. PCR TECHNOLOGIES MARKET - ASIA PACIFIC MARKET ANALYSIS
5.1 PCR Technologies Market Revenue (US$ Million), 2020 - 2030
6. ASIA PACIFIC PCR TECHNOLOGIES MARKET ANALYSIS - BY TECHNOLOGY
6.1 Overview
6.2 Real Time PCR
6.2.1 Overview
6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Conventional PCR
6.3.1 Overview
6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Reverse Transcription PCR
6.4.1 Overview
6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.5 Digital PCR
6.5.1 Overview
6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.6 Multiplex RT PCR
6.6.1 Overview
6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.7 Hot Start PCR
6.7.1 Overview
6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.8 Others
6.8.1 Overview
6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
7. ASIA PACIFIC PCR TECHNOLOGIES MARKET ANALYSIS - BY OFFERINGS
7.1 Overview
7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
7.3 Reagents and Consumables
7.3.1 Overview
7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
7.3.2.1.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
7.5 Software and Services
7.5.1 Overview
7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)
8. ASIA PACIFIC PCR TECHNOLOGIES MARKET ANALYSIS - BY APPLICATION
8.1 Overview
8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Gene Expression Analysis
8.3.1 Overview
8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Genetic Sequencing
8.4.1 Overview
8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
8.5 Genotyping
8.5.1 Overview
8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
8.6 Nucleic Acid Synthesis
8.6.1 Overview
8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
8.7 Standard Validation
8.7.1 Overview
8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
8.8 Point of Care Diagnostics
8.8.1 Overview
8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
8.9 Environmental Application
8.9.1 Overview
8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
8.10 Others
8.10.1 Overview
8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
9. ASIA PACIFIC PCR TECHNOLOGIES MARKET ANALYSIS - BY END USER
9.1 Overview
9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals and Diagnostic Centers
9.3.1 Overview
9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
9.4 Academia and Research Institutes
9.4.1 Overview
9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
9.5 Pharmaceutical and Biotechnology Companies
9.5.1 Overview
9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
10. ASIA PACIFIC PCR TECHNOLOGIES MARKET -COUNTRY ANALYSIS
10.1 Asia Pacific: PCR Technologies Market
10.1.1 Overview
10.1.2 Asia Pacific PCR Technologies Market Revenue and Forecast and Analysis - By Country
10.1.2.1 China
10.1.2.1.1 Overview
10.1.2.2 China PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.2.1 China PCR Technologies Market Breakdown by Technology
10.1.2.2.2 China PCR Technologies Market Breakdown by Offerings
10.1.2.2.2.1 China PCR Technologies Market Breakdown by Instruments
10.1.2.2.2.2 China PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.2.2.2.1 China PCR Technologies Market Breakdown by Vial Size
10.1.2.2.3 China PCR Technologies Market Breakdown by Application
10.1.2.2.4 China PCR Technologies Market Breakdown by End User
10.1.2.3 Japan
10.1.2.3.1 Overview
10.1.2.4 Japan PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.4.1 Japan PCR Technologies Market Breakdown by Technology
10.1.2.4.2 Japan PCR Technologies Market Breakdown by Offerings
10.1.2.4.2.1 Japan PCR Technologies Market Breakdown by Instruments
10.1.2.4.2.2 Japan PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.4.2.2.1 Japan PCR Technologies Market Breakdown by Vial Size
10.1.2.4.3 Japan PCR Technologies Market Breakdown by Application
10.1.2.4.4 Japan PCR Technologies Market Breakdown by End User
10.1.2.5 India
10.1.2.5.1 Overview
10.1.2.6 India PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.6.1 India PCR Technologies Market Breakdown by Technology
10.1.2.6.2 India PCR Technologies Market Breakdown by Offerings
10.1.2.6.2.1 India PCR Technologies Market Breakdown by Instruments
10.1.2.6.2.2 India PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.6.2.2.1 India PCR Technologies Market Breakdown by Vial Size
10.1.2.6.3 India PCR Technologies Market Breakdown by Application
10.1.2.6.4 India PCR Technologies Market Breakdown by End User
10.1.2.7 Australia
10.1.2.7.1 Overview
10.1.2.8 Australia PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.8.1 Australia PCR Technologies Market Breakdown by Technology
10.1.2.8.2 Australia PCR Technologies Market Breakdown by Offerings
10.1.2.8.2.1 Australia PCR Technologies Market Breakdown by Instruments
10.1.2.8.2.2 Australia PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.8.2.2.1 Australia PCR Technologies Market Breakdown by Vial Size
10.1.2.8.3 Australia PCR Technologies Market Breakdown by Application
10.1.2.8.4 Australia PCR Technologies Market Breakdown by End User
10.1.2.9 South Korea
10.1.2.9.1 Overview
10.1.2.10 South Korea PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.10.1 South Korea PCR Technologies Market Breakdown by Technology
10.1.2.10.2 South Korea PCR Technologies Market Breakdown by Offerings
10.1.2.10.2.1 South Korea PCR Technologies Market Breakdown by Instruments
10.1.2.10.2.2 South Korea PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.10.2.2.1 South Korea PCR Technologies Market Breakdown by Vial Size
10.1.2.10.3 South Korea PCR Technologies Market Breakdown by Application
10.1.2.10.4 South Korea PCR Technologies Market Breakdown by End User
10.1.2.11 Rest of Asia Pacific
10.1.2.11.1 Overview
10.1.2.12 Rest of Asia Pacific PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.12.1 Rest of Asia Pacific PCR Technologies Market Breakdown by Technology
10.1.2.12.2 Rest of Asia Pacific PCR Technologies Market Breakdown by Offerings
10.1.2.12.2.1 Rest of Asia Pacific PCR Technologies Market Breakdown by Instruments
10.1.2.12.2.2 Rest of Asia Pacific PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.12.2.2.1 Rest of Asia Pacific PCR Technologies Market Breakdown by Vial Size
10.1.2.12.3 Rest of Asia Pacific PCR Technologies Market Breakdown by Application
10.1.2.12.4 Rest of Asia Pacific PCR Technologies Market Breakdown by End User
11. PCR TECHNOLOGIES MARKET-INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the PCR Technologies Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Thermo Fisher Scientific Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Promega Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN NV
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 bioMerieux SA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Hoffmann-La Roche Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Bio-Rad Laboratories Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Becton Dickinson and Co
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Takara Bio Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Standard Biotools Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Agilent Technologies Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Ellume Ltd
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. APPENDIX
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. PCR Technologies Market Segmentation
Table 2. PCR Technologies Market - Revenue and Forecast to 2030 (US$ Million) - By Technology
Table 3. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Offerings
Table 4. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
Table 5. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
Table 6. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
Table 7. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Application
Table 8. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By End User
Table 9. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 10. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 11. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 12. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 13. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 14. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 15. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 16. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 17. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 18. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 19. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 20. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 21. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 22. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 23. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 24. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 25. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 26. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 27. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 28. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 29. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 30. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 31. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 32. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 33. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 34. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 35. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 36. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 37. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 38. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 39. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 40. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 41. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 42. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 43. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 44. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 45. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 46. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 47. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 48. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 49. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 50. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 51. Recent Inorganic Growth Strategies in the PCR Technologies Market
Table 52. Recent Organic Growth Strategies in the PCR Technologies Market
Table 53. Glossary of Terms, PCR Technologies Market12. List of Figures
Figure 1. PCR Technologies Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. PCR Technologies Market Revenue (US$ Million), 2020 - 2030
Figure 4. PCR Technologies Market Share (%) - By Technology, 2022 and 2030
Figure 5. Real Time PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Conventional PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Reverse Transcription PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Digital PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. Multiplex RT PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 10. Hot Start PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. PCR Technologies Market Share (%) - By Offerings, 2022 and 2030
Figure 13. Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Instruments Market Revenue and Forecasts to 2030 (US$ Million)
Figure 15. Software and Services Market Revenue and Forecasts to 2030 (US$ Million)
Figure 16. PCR Technologies Market Share (%) - By Application, 2022 and 2030
Figure 17. Gene Expression Analysis Market Revenue and Forecasts to 2030 (US$ Million)
Figure 18. Genetic Sequencing Market Revenue and Forecasts to 2030 (US$ Million)
Figure 19. Genotyping Market Revenue and Forecasts to 2030 (US$ Million)
Figure 20. Nucleic Acid Synthesis Market Revenue and Forecasts to 2030 (US$ Million)
Figure 21. Standard Validation Market Revenue and Forecasts to 2030 (US$ Million)
Figure 22. Point of Care Diagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 23. Environmental Application Market Revenue and Forecasts to 2030 (US$ Million)
Figure 24. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 25. PCR Technologies Market Share (%) - By End User, 2022 and 2030
Figure 26. Hospitals and Diagnostic Centers Market Revenue and Forecasts to 2030 (US$ Million)
Figure 27. Academia and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
Figure 28. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
Figure 29. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 30. Asia Pacific: PCR Technologies Market, by Key Country - Revenue (2022) (US$ Million)
Figure 31. Asia Pacific PCR Technologies Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 32. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 33. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 34. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 35. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 36. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 37. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 38. Growth Strategies in the PCR Technologies Market
Table 1. PCR Technologies Market Segmentation
Table 2. PCR Technologies Market - Revenue and Forecast to 2030 (US$ Million) - By Technology
Table 3. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Offerings
Table 4. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
Table 5. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
Table 6. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
Table 7. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Application
Table 8. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By End User
Table 9. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 10. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 11. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 12. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 13. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 14. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 15. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 16. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 17. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 18. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 19. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 20. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 21. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 22. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 23. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 24. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 25. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 26. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 27. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 28. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 29. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 30. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 31. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 32. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 33. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 34. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 35. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 36. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 37. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 38. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 39. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 40. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 41. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 42. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 43. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 44. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 45. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 46. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 47. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 48. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 49. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 50. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 51. Recent Inorganic Growth Strategies in the PCR Technologies Market
Table 52. Recent Organic Growth Strategies in the PCR Technologies Market
Table 53. Glossary of Terms, PCR Technologies Market12. List of Figures
Figure 1. PCR Technologies Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. PCR Technologies Market Revenue (US$ Million), 2020 - 2030
Figure 4. PCR Technologies Market Share (%) - By Technology, 2022 and 2030
Figure 5. Real Time PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Conventional PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Reverse Transcription PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Digital PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. Multiplex RT PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 10. Hot Start PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. PCR Technologies Market Share (%) - By Offerings, 2022 and 2030
Figure 13. Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Instruments Market Revenue and Forecasts to 2030 (US$ Million)
Figure 15. Software and Services Market Revenue and Forecasts to 2030 (US$ Million)
Figure 16. PCR Technologies Market Share (%) - By Application, 2022 and 2030
Figure 17. Gene Expression Analysis Market Revenue and Forecasts to 2030 (US$ Million)
Figure 18. Genetic Sequencing Market Revenue and Forecasts to 2030 (US$ Million)
Figure 19. Genotyping Market Revenue and Forecasts to 2030 (US$ Million)
Figure 20. Nucleic Acid Synthesis Market Revenue and Forecasts to 2030 (US$ Million)
Figure 21. Standard Validation Market Revenue and Forecasts to 2030 (US$ Million)
Figure 22. Point of Care Diagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 23. Environmental Application Market Revenue and Forecasts to 2030 (US$ Million)
Figure 24. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 25. PCR Technologies Market Share (%) - By End User, 2022 and 2030
Figure 26. Hospitals and Diagnostic Centers Market Revenue and Forecasts to 2030 (US$ Million)
Figure 27. Academia and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
Figure 28. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
Figure 29. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 30. Asia Pacific: PCR Technologies Market, by Key Country - Revenue (2022) (US$ Million)
Figure 31. Asia Pacific PCR Technologies Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 32. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 33. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 34. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 35. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 36. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 37. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 38. Growth Strategies in the PCR Technologies Market
